Showing results (161-170 of 266) with videos related to
Sort By:
Pageof 27
Journal of Clinical Microbiology|October 11, 2013
Exploring alternative biomaterials for diagnosis of pulmonary tuberculosis in HIV-negative patients by use of the GeneXpert MTB/RIF assayShubhada Shenai, Danielle Amisano, Katharina Ronacher, et al.Scientific Reports|August 20, 2017
NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humansMartin Gengenbacher, Maria A Duque-Correa, Peggy Kaiser, et al.Journal of the American Chemical Society|October 8, 2009
Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signalsColin A Lowery, Junguk Park, Christian Gloeckner, et al.Proceedings of the National Academy of Sciences of the United States of America|January 28, 2015
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule deliveryMeenal Datta, Laura E Via, Walid S Kamoun, et al.Biorxiv : the Preprint Server for Biology|May 25, 2026
In vitro dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesionsJoshua J Whiteley, Talia Greenstein, Mariana Pereira Moraes, et al.Science (New York, N.Y.)|November 29, 2008
PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO releaseRamandeep Singh, Ujjini Manjunatha, Helena I M Boshoff, et al.Journal of Clinical Microbiology|December 31, 2010
Rapid detection of fluoroquinolone-resistant and heteroresistant Mycobacterium tuberculosis by use of sloppy molecular beacons and dual melting-temperature codes in a real-time PCR assaySoumitesh Chakravorty, Bola Aladegbami, Kimberley Thoms, et al.Plos One|August 21, 2014
Pharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisSuresh B Lakshminarayana, Helena I M Boshoff, Joseph Cherian, et al.Respiration; International Review of Thoracic Diseases|February 11, 2010
Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosisSeok-Yong Eum, Ye-Jin Lee, Jin-Hong Min, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2005
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugsEdward A Weinstein, Takahiro Yano, Lin-Sheng Li, et al.Pageof 27